Tom Ormrod joins firm
M&G latest to launch new service
First onshore product from RARE
Healthcare was one sector that did not fully participate in the recent stockmarket rally and finished the first quarter as the worst performer in the S&P 500 index, writes Legg Mason's Evan Bauman.
Follows withdrawal of majority stakeholder
7,000 clients representing £65m AUM
Over 5,000 investors surveyed